Controversial vaccine official Dr. Vinay Prasad departs FDA
"Dr. Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family," HHS said. "We thank him for his service and the many important reforms he was able to achieve in his time at FDA."
Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, replacing Dr. Peter Marks, who had been forced out by HHS Secretary Robert F. Kennedy Jr. Prasad was subsequently named chief medical and scientific officer, absorbing the roles of other top-ranking FDA officials who were removed or left under the Trump administration.
In recent weeks, right-wing influencer Laura Loomer had launched a social media campaign against Prasad, highlighting his past support for Democrats, including Sen. Bernie Sanders. Loomer called Prasad a "Lifelong Progressive with a Vicious Anti-Trump Record" and writing that "Prasad's views are a slap in the face to the conservative values of limited government, deregulation, and economic freedom that YOU voted for!"
But FDA chief Marty Markay over the weekend had defended Prasad over Loomer's comments, saying in a Politico podcast that Prasad is a "impeccable scientist … one of the greatest scientific minds of our generation."
Long a critic of the FDA for granting emergency use authorization for COVID-19 vaccine boosters, Prasad had called Marks "one of the most dangerous, pro-pharma regulators of the 21st century" and said he was "either incompetent or corrupt to authorize a booster without clinical, randomized data."
In his three-month tenure at the FDA, the agency decided to limit COVID-19 vaccine recommendations to people 65 years of age and older and others who are at high risk of becoming seriously ill if they are infected, and will require manufacturers to conduct clinical trials to show whether the vaccines are of benefit to healthy younger adults and children.
Earlier this month, the FDA released records that showed Prasad overrode career staff at the agency to limit the approvals of COVID-19 shots from Novavax and Moderna. Alexander Tin
contributed to this report.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
a minute ago
- Forbes
A Big, Beautiful Fiction - Does The EU/US Trade Deal Make Sense?
James Thurber's famous book 'The Secret Life of Walter Mitty' is yet another book I would recommend to readers, to continue a recurring theme of recent weeks. It is especially apt in the context of the US-EU trade deal. Walter Mitty appeared at the end of the 1930's, a decade that was shaped by Herbert Hoover's tariff policy, and that was marked by profound economic and geopolitical tensions. Mitty's fantasies were provoked by the reality of his pedestrian, harangued life – which will appeal to European leaders who care to dream of better days. Equally, the giddiness of Mitty's fantasies has its equivalent in the promises that Donald Trump has elicited from the EU – namely, to buy and invest hundreds of billions of dollars in energy. One week on, reaction to the US-EU trade deal is still mixed, and it is not quite clear who has 'won'. This may be because it is not a trade deal in the classical sense – at least in the sense of the laborious trade deals that the EU is used to striking, partly because a large facet of the 'deal' is based on a promise and also because the optics of the deal are quite depressing for Europe. At the headline level, EU exports into the US will be met with a 15% tariff to be paid by the US consumer, not unlike the Japanese 'deal'. Auto companies will not be displeased with a 15% tariff. Wines and spirits, steel and notably pharmaceuticals have yet to have tariff levels finalised and there will be some relief on the confirmation of 15% tariffs on pharmaceuticals, though the investigation into pharmaceutical exports back to the US is a tail risk. Interestingly, the EU has resisted attempts to water down its digital regulations. Politically the spin that the EU is putting on the agreement is that it was the best possible outcome in a difficult geopolitical climate (recall that the recent EU-China summit was a damp-squib). While there were some public expressions of dismay, notably from the French prime minister Francois Bayrou – these can be seen to be largely aimed at the public, rather than Brussels. Though Ursula von der Leyen is unpopular with EU governments for the singular way she runs her office – it is populated with officials who are close to national government (i.e. Alexandre Adam one of von der Leyen's key deputies is an arch Macronist) – there is no sense that the large countries were left out of the negotiation process, and any effort to isolate von der Leyen for blame, is ignoble. However, amongst the professional trade staff, there is still some despair at the humiliating optics of the deal, the fact that it is in many ways not binding, and the risk that there is no undertaking that it is final in the sense that another round of tariffs is imposed later. On the positive side for Europe, and flipping to the 'Mitty-esque' part of the deal, two of the key undertakings in the deal – that European companies invest USD 600 bn in the US, in addition to a commitment to purchase microchips, as well as a commitment from the EU to buy USD 750bn in energy from the US over the course of the Trump presidency – are not at all clear in their implementation, and very much open to a fudge, with the right accounting treatment. In particular the energy purchase commitment is unrealistic because it exceeds what the EU spends on energy in a given year and US energy firms do not have the capacity to service a commitment of USD 250bn in demand from Europe, whilst also serving other markets. In my view there are several aftershocks to watch for. The first is that the deal further damages trans-Atlantic relations, and the level of trust between the EU and the US is likely the lowest it has ever been, and this has strategic implications as far afield as Russia/Ukraine and the Middle East. One other implication may be a drift, by government and consumers, away from US brands – as this may well be an effect that is seen in other regions. Two financial market implications are that the dampening of growth in Europe will maintain downward pressure on rates in Europe. More importantly, in the context of a very oversold dollar, there is now an incentive for EU policy makers to try hard to talk down the euro, and we may see a short-term rebound in the currency pair. On the whole, if this is a 'final' deal and the topic of tariffs does not re-emerge in the next three years, it is not a bad deal for the semi's, autos and aerospace sectors in Europe, though the public optics are not good for the EU. The best parts of the deal for Europe are the fantastical claims of incoming European investment and energy purchases in the US. This is a Mitty style fairy tale that the Europeans hope Mr Trump believes in. The telling factor is that this deal has now emptied all goodwill from the trans-Atlantic relationship, and effectively completes another diplomatic rupture by President Trump. From a European point of view, this is yet another 'wake up call' and the best that can be hoped for is that it accelerates projects like the savings and investment union and 'strategic autonomy'. European leaders and the European policy elite keep talking about this, but until we see hard evidence (for example, German real GDP over the last five years is close to zero), they are the fantasists. Have a great week ahead Mike
Fox News
a minute ago
- Fox News
Kamala Harris: I refused to 'pile on' Joe Biden
Kamala Harris bristled at Stephen Colbert's question about navigating a campaign to replace her own boss.
Yahoo
28 minutes ago
- Yahoo
Trump signs order imposing new tariffs on a number of trading partners
President Donald Trump has signed an executive order that sets new tariffs on a wide swath of US trading partners to go into effect on August 7. The move is the next step in his trade agenda that will test the global economy and sturdiness of American alliances built up over decades. The order was issued shortly after 7pm on Thursday. It came after a flurry of tariff-related activity in the last several days, as the White House announced agreements with various nations and blocs ahead of the president's self-imposed Friday deadline. The tariffs are being implemented at a later date in order for the rates schedule to be harmonised, according to a senior administration official who spoke to reporters on a call on the condition of anonymity. After initially threatening the African nation of Lesotho with a 50% tariff, the country's goods will now be taxed at 15%. Taiwan will have tariffs set at 20%, Pakistan at 19% and Israel, Iceland, Norway, Fiji, Ghana, Guyana and Ecuador among the countries with imported goods taxed at 15%. Switzerland would be tariffed at 39%. Mr Trump had announced a 50% tariff on goods from Brazil, but the order was only 10% as the other 40% were part of a separate measure approved on Wednesday. The order capped off a hectic Thursday as nations sought to continue negotiating with Mr Trump. It set the rates for 68 countries and the 27-member European Union, with a baseline 10% rate to be charged on countries not listed in the order. The senior administration official said the rates were based on trade imbalance with the US and regional economic profiles. On Thursday morning, Mr Trump engaged in a phone conversation with Mexican president Claudia Sheinbaum on trade. As a result of the conversation, the US president said he would enter into a 90-day negotiating period with Mexico, one of the nation's largest trading partners. The current 25% tariff rates are staying in place, down from the 30% he had threatened earlier. 'We avoided the tariff increase announced for tomorrow and we got 90 days to build a long-term agreement through dialogue,' Ms Sheinbaum wrote on X after a call with Mr Trump that he referred to as 'very successful' in terms of the leaders getting to know each other better. The unknowns created a sense of drama that has defined Mr Trump's rollout of tariffs over several months. However, the one consistency is his desire to levy the import taxes that most economists say will ultimately be borne to some degree by US consumers and businesses. 'We have made a few deals today that are excellent deals for the country,' Mr Trump told reporters on Thursday afternoon, without detailing the terms of those agreements or the nations involved. The senior administration official declined to reveal the nations that have new deals during the call with reporters. Mr Trump said that Canadian prime minister Mark Carney had called ahead of 35% tariffs being imposed on many of his nation's goods, but 'we haven't spoken to Canada today'. Mr Trump separately on Thursday amended a previous order to raise the fentanyl-related tariff on Canada from 25% to 35%. Mr Trump had imposed the Friday deadline after his previous 'Liberation Day' tariffs in April resulted in a stock market panic. His unusually high tariff rates, unveiled in April, led to recession fears — prompting Mr Trump to impose a 90-day negotiating period. When he was unable to create enough trade deals with other countries, he extended the timeline and sent out letters to world leaders that simply listed rates, prompting a slew of hasty deals. Mr Trump reached a deal with South Korea on Wednesday, and earlier with the European Union, Japan, Indonesia and the Philippines. His commerce secretary, Howard Lutnick, said on Fox News Channel's Hannity that there were agreements with Cambodia and Thailand after they had agreed to a ceasefire to their border conflict. Going into Thursday, wealthy Switzerland and Norway were still uncertain about their tariff rates. EU officials were waiting to complete a crucial document outlining how the framework to tax imported cars and other goods from the 27-member state bloc would operate. Mr Trump had announced a deal on Sunday while he was in Scotland. Mr Trump said as part of the agreement with Mexico that goods imported into the US would continue to face a 25% tariff that he has ostensibly linked to fentanyl trafficking. He said cars would face a 25% tariff, while copper, aluminium and steel would be taxed at 50% during the negotiating period.
